title: [PREDICTING FACTORS OF THE LIFE SPAN IN PATIENTS, SUFFERING METASTATIC COLORECTAL CANCER AND SYNCHRONOUS HEPATIC AFFECTION AFTER SURGICAL TREATMENT].
abstract: The results of treatment of 125 patients, suffering metastatic hepatic affection in colorectal cancer (pT1--4N0--2M1--in colonic cancer and pT1--3N0--2M1--in cancer recti), to whom in 2008-2015 yrs a one-staged (Group 1) or two-staged (Group II) surgical treatment was done. In affection of 4 regional lymph nodes and more (pN2) late results were less favorable, than in pN1 or pN0, not depending from surgical approach choosed. In 48 (38.4%) patients with one syndromal hepatic metastatic focus, the indices of general three-year and five-year cumulative survival were the best, than in other groups--82 and 63% (p = 0.001) accordingly; in monolobar affection--68 and 49%, and in bilobar--23 and 0%, not depending from method of surgical treatment (p < 0.001) choosed. Predictive factors were established, which impact negatively the indices of general survival in patients, suffering metastatic hepatic affection in colorectal cancer: hepatic metastatic foci number 4 and more, bilobar hepatic metastatic affection.
authors.forename: O O
authors.initials: OO
authors.lastname: Kolesnik
authors.forename: A A
authors.initials: AA
authors.lastname: Burlaka
authors.forename: A V
authors.initials: AV
authors.lastname: Lukashenko
authors.forename: V V
authors.initials: VV
authors.lastname: Pryimak
authors.forename: Yu O
authors.initials: YO
authors.lastname: Zhukov
authors.forename: D E
authors.initials: DE
authors.lastname: Makhmudov
authors.forename: M O
authors.initials: MO
authors.lastname: Volk
authors.forename: I B
authors.initials: IB
authors.lastname: Shchepotin
mesh_terms: D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000401:mortality* / Q000473:pathology / Q000601:surgery; D005260:Female; D006498:Hepatectomy / Q000379:methods*; D006801:Humans; D008099:Liver / Q000473:pathology / Q000601:surgery; D008113:Liver Neoplasms / Q000175:diagnosis* / Q000401:mortality* / Q000556:secondary / Q000601:surgery; D008198:Lymph Nodes / Q000473:pathology / Q000601:surgery; D008207:Lymphatic Metastasis; D008297:Male; D060787:Neoplasm Grading; D009367:Neoplasm Staging; D011379:Prognosis; D012007:Rectum / Q000473:pathology / Q000601:surgery; D012307:Risk Factors; D016019:Survival Analysis